Immunogenicity and Safety of a Trivalent Inactivated Influenza Vaccine, Formulation 2010-2011, in Healthy Subjects Aged Over 6 Months Old to 18 Years Old
Clinical trial NCT01356342 · COMPLETED
Trial details
- NCT number
- NCT01356342
- Sponsor
- Adimmune Corporation
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2010-07-01
- Primary completion
- 2011-04-01
- Enrollment
- 181
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.